In this study, we described the mutational landscape and the unique molecular characteristics of DPC, especially PBRM1‐inactivating mutations and the PBRM1‐c‐JUN‐VIM axis, which serve as important methods of cancer invasion and were associated with poor patient outcomes in DPC. The gene discussed is PBRM1; the disease is cancer.